Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Language Scientific and Clinical Outcomes at Oxford University Innovation Announce Collaboration for Translation, Linguistic Validation and COA Management Services

Language Scientific is proud to announce a new collaboration with Oxford University Innovation for translation, linguistic validation services and COA management services.


News provided by

Language Scientific

Jun 10, 2020, 11:00 ET

Share this article

Share toX

Share this article

Share toX


MEDFORD, Mass., June 10, 2020 /PRNewswire-PRWeb/ -- Language Scientific, Inc., the leading medical and scientific translation company, is pleased to announce a new innovative collaboration with Oxford University Innovation Ltd, the premier provider of Clinical Outcome Assessment (COA) management services. This strategic collaboration will allow for COA copyright owners and authors to reduce the time they spend managing health outcome measures as well as enable their instruments to be widely used in global study sites through robust translation, linguistic validation and cognitive debriefing of clinical questionnaires.

Reaching the widest possible audience whilst protecting the integrity of the instrument can be difficult when managing a COA instrument in house. It can become burdensome keeping track of users, licensees, translations, platforms and unauthorized or improper use of your COA. The Clinical Outcomes Team at Oxford University Innovation (The University of Oxford's wholly owned technology transfer company) specializes in the dedicated, world class professional management of COA Instruments. They offer industry leading expertise assisting with COA development through their experience in managing all aspects of the licensing process, user support and comprehensive creative marketing.

Language Scientific is always looking to collaborate with highly respected organizations that put quality first such as Oxford University Innovation.

Post this

Language Scientific's experienced project managers, certified translators, in-country investigators, clinicians, psychologists, linguists and other professionals, combined with ISO 9001:2015 and ISO 17100:2015 certified processes, ensure that the linguistic validation of COAs and eCOAs are both culturally appropriate and conceptually equivalent. Language Scientific's Linguistic Validation services verify that translations of all items are interpreted in the same way across target populations and regions and have the same content validity. This ensures that measurement properties of the items will be the same across different language versions of the instrument and that data can be validly pooled across international sites and that the process will meet FDA and EMEA guidelines.

Oxford University Innovation is collaborating with Language Scientific to provide linguistic validation and translation services because of LS' extensive experience and highest quality reputation in assisting clinical, medical and scientific organizations. Language Scientific has over 20 years of experience providing clinical translation, linguistic validation and cognitive debriefing services in over 215 languages to customers such as Amgen, Merck Healthcare KGaA, Eli Lilly, Intercept Pharmaceuticals, Novo Nordisk and Roche. Their team of industry expert linguists and clinicians reside in over 120 countries and are assigned to a project based on their experience in the appropriate therapeutic area.

"At Language Scientific, we craft unique solutions for leading pharmaceutical companies and universities. This has enabled us to create a successful linguistic validation practice focused on providing the highest quality service to our customers" says LS CEO Sharon Blank. "By leveraging our native speaking medical professional linguists, we are able to provide the highest quality translations for our partners. Language Scientific is always looking to collaborate with highly respected organizations that put quality first such as Oxford University Innovation. I am thrilled to be announcing our partnership and look forward to leveraging our extensive Linguistic Validation and Cognitive Debriefing experience."

"The Clinical Outcomes team at Oxford University Innovation prides itself on providing the highest quality services for our clients, so I was very pleased to find a delivery partner in Language Scientific who share our passion for quality in service delivery" says Dr. David Churchman Clinical Outcomes – Business Manager. "I am really pleased to be able to offer our clients the services of a highly specialized company such as Language Scientific, that puts the high quality of their translations first and foremost."

About Language Scientific, Inc. ®

Language Scientific, Inc. is a US-based globalization company specializing in clinical, medical, scientific and technical language and linguistic validation services and solutions with a record of more than 20 years of excellence in over 215 languages. Language Scientific serves more than 1,500 clients in the pharmaceutical, clinical, and medical device industries, from Fortune 500 companies to small emerging companies. Our specialization, focus, innovation and customer-centered attitude have earned us the trust of many of the world's leading life sciences companies. For more information, visit: https://www.languagescientific.com or email: [email protected].

Certifications
ISO 9001:2008
ISO 17100:2015
https://www.languagescientific.com

About Oxford University Innovation Ltd.
Clinical Outcomes (at Oxford University Innovation) is a UK-based company, solely owned by the University of Oxford, specializing in the management and support of high-quality Clinical Outcome Assessments. The Clinical Outcomes team has been active in supporting COA users for over 14 years and represents the wishes of COA developers from within academia, healthcare providers and commercial organizations. Our international clients, which includes over 750 new users every year, covers the healthcare spectrum including academic research, publicly and independently funded healthcare providers, medical device companies and the pharmaceutical sector. For more information, visit https://innovation.ox.ac.uk/clinical-outcomes/ or email [email protected].

SOURCE Language Scientific

Related Links

http://www.languagescientific.com

Modal title

LS OUI Press Release PDF
View PDF
LS OUI Press Release PDF
LS OUI Press Release PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.